Efraim H Rosenberg
Overview
Explore the profile of Efraim H Rosenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla M, et al.
Breast Cancer Res
. 2024 Dec;
26(1):189.
PMID: 39734228
Background: The 313-variant polygenic risk score (PRS) provides a promising tool for clinical breast cancer risk prediction. However, evaluation of the PRS across different European populations which could influence risk...
2.
Talens F, Teixeira V, Kok Y, Chen M, Rosenberg E, Debipersad R, et al.
NAR Cancer
. 2024 Nov;
6(4):zcae044.
PMID: 39611179
Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPis) are currently used to treat mutant cancers. Although PARPi sensitivity has been attributed to homologous recombination (HR) defects, other roles of HR factors have also...
3.
Zanti M, OMahony D, Parsons M, Li H, Dennis J, Aittomakkiki K, et al.
Hum Mutat
. 2024 May;
2023.
PMID: 38725546
A large number of variants identified through clinical genetic testing in disease susceptibility genes, are of uncertain significance (VUS). Following the recommendations of the American College of Medical Genetics and...
4.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla M, et al.
medRxiv
. 2024 Feb;
PMID: 38410445
The 313-variant polygenic risk score (PRS) provides a promising tool for breast cancer risk prediction. However, evaluation of the PRS across different European populations which could influence risk estimation has...
5.
Wang Y, Dackus G, Rosenberg E, Cornelissen S, de Boo L, Broeks A, et al.
BMC Med
. 2024 Jan;
22(1):9.
PMID: 38191387
Background: Due to the abundant usage of chemotherapy in young triple-negative breast cancer (TNBC) patients, the unbiased prognostic value of BRCA1-related biomarkers in this population remains unclear. In addition, whether...
6.
Samsom K, Bosch L, Schipper L, Schout D, Roepman P, Boelens M, et al.
Nat Protoc
. 2023 Dec;
19(3):700-726.
PMID: 38092944
Two decades after the genomics revolution, oncology is rapidly transforming into a genome-driven discipline, yet routine cancer diagnostics is still mainly microscopy based, except for tumor type-specific predictive molecular tests....
7.
Koster R, Schipper L, Giesbertz N, van Beek D, Mendeville M, Samsom K, et al.
Genet Med
. 2023 Nov;
26(2):101032.
PMID: 38006283
Purpose: Genome sequencing (GS) enables comprehensive molecular analysis of tumors and identification of hereditary cancer predisposition. According to guidelines, directly determining pathogenic germline variants (PGVs) requires pretest genetic counseling, which...
8.
van Wagensveld L, van Baal J, Timmermans M, Gaillard D, Borghuis L, Coffelt S, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497449
Background: How molecular profiles are associated with tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC) is incompletely understood. Therefore, we analyzed the TME and molecular profiles of HGSOC and...
9.
Hakkaart C, Pearson J, Marquart L, Dennis J, Wiggins G, Barnes D, et al.
Commun Biol
. 2022 Oct;
5(1):1061.
PMID: 36203093
The contribution of germline copy number variants (CNVs) to risk of developing cancer in individuals with pathogenic BRCA1 or BRCA2 variants remains relatively unknown. We conducted the largest genome-wide analysis...
10.
Rigter L, Snaebjornsson P, Rosenberg E, Altena E, van Grieken N, Aleman B, et al.
PLoS One
. 2022 Jul;
17(7):e0270591.
PMID: 35877698
Introduction: The risk of developing gastric cancer is increased in patients treated with radiotherapy for Hodgkin lymphoma (HL) or testicular cancer (TC). This study aims to assess if gastric adenocarcinoma...